Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Epidermal growth factor receptor structure, regulation, mitogenic signalling and effects of activation.

Boulougouris P, Elder J.

Anticancer Res. 2001 Jul-Aug;21(4A):2769-75. Review.

PMID:
11724353
2.

CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.

Walker F, Orchard SG, Jorissen RN, Hall NE, Zhang HH, Hoyne PA, Adams TE, Johns TG, Ward C, Garrett TP, Zhu HJ, Nerrie M, Scott AM, Nice EC, Burgess AW.

J Biol Chem. 2004 May 21;279(21):22387-98. Epub 2004 Mar 11.

3.
4.
6.

Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.

Greco S, Muscella A, Elia MG, Romano S, Storelli C, Marsigliante S.

J Cell Physiol. 2004 Oct;201(1):84-96.

PMID:
15281091
7.
8.

Comparative mitogenic potencies of EGF and TGF alpha and their dependence on receptor-limitation versus ligand-limitation.

Reddy CC, Wells A, Lauffenburger DA.

Med Biol Eng Comput. 1998 Jul;36(4):499-507.

PMID:
10198537
9.
10.

Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.

Yan F, Hui YN, Li YJ, Guo CM, Meng H.

Ophthalmologica. 2007;221(4):244-50.

PMID:
17579290
11.
12.

Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells.

Buerger C, Nagel-Wolfrum K, Kunz C, Wittig I, Butz K, Hoppe-Seyler F, Groner B.

J Biol Chem. 2003 Sep 26;278(39):37610-21. Epub 2003 Jul 2.

13.

SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.

Zhang Q, Thomas SM, Xi S, Smithgall TE, Siegfried JM, Kamens J, Gooding WE, Grandis JR.

Cancer Res. 2004 Sep 1;64(17):6166-73.

14.

Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.

Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ.

Diabetes. 2002 Apr;51(4):966-76.

16.

Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP.

Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, Ivaska J.

Nat Cell Biol. 2005 Jan;7(1):78-85. Epub 2004 Dec 12.

PMID:
15592458
17.

The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode.

Dong J, Opresko LK, Chrisler W, Orr G, Quesenberry RD, Lauffenburger DA, Wiley HS.

Mol Biol Cell. 2005 Jun;16(6):2984-98. Epub 2005 Apr 13.

19.

Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.

Zhang T, Ma J, Cao X.

Biochem J. 2003 Dec 1;376(Pt 2):457-64.

20.

EGF AND TGF-alpha motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms.

Ellis IR, Schor AM, Schor SL.

Exp Cell Res. 2007 Feb 15;313(4):732-41. Epub 2006 Dec 5.

PMID:
17196962
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk